# A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

> **NCT00377442** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 33 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** GK Activator (2)
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00377442
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377442, "A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00377442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*